Rockefeller Capital Management
ACER

Rockefeller Capital Management’s Acer Therapeutics Inc ACER Stock Holding History

Rockefeller Capital Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,500
Closed -$9K – 4522
2022
Q2 		$9K Buy
+7,500
New +$15.7K ﹤0.01% 3203

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CF
Copperwynd Financial Scottsdale, Arizona $401M AUM 20.7% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockefeller Capital Management's ACER Position: Q3 2022 in Review

Rockefeller Capital Management sold out of Acer Therapeutics Inc (ACER) in Q3 2022, closing a stake of 7,500 shares — an estimated $9K sold.

Rockefeller Capital Management first reported a position in ACER in Q2 2022 and held it in 1 quarter. The position peaked at $9K in Q2 2022. 28 funds tracked by Wall St. Rank hold ACER as of Q3 2022.

  • Rockefeller Capital Management reported no remaining Acer Therapeutics Inc position as of Q3 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 7,500 Acer Therapeutics Inc shares in Q3 2022, an estimated $9K.
  • Rockefeller Capital Management first reported a position in Acer Therapeutics Inc in Q2 2022 and held it in 1 quarter.
  • Rockefeller Capital Management's Acer Therapeutics Inc position peaked at $9K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2022.

Based on Rockefeller Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.